Macroarray analysis in the hypertrophic left ventricle of renin-dependent hypertensive rats: Identification of target genes for renin

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 5, Issue 2, 2004, Pages 72-78

  Kurdi, Mazen ^a   Cerutti, Catherine ^a   Randon, Jacques ^a   McGregor, Lilian ^a   Bricca, Giampiero ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

AMPK; APLP2; APP; Biglycan; cDNA array; Gene expression; Genetically hypertensive rats; Hypertension; YWK II

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; AMYLOID PRECURSOR LIKE PROTEIN 2; AMYLOID PRECURSOR PROTEIN; BIGLYCAN; COMPLEMENTARY DNA; MESSENGER RNA; RENIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DNA HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HORMONE ACTION; HYPERTENSION; MALE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL ANALYSIS; TRANSGENIC ANIMAL;

EID: 3543036378     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2004.013     Document Type: Article

References (46)

1. Hamet P. Environmentally-regulated genes of hypertension. Clin Exp Hypertens 1996;18:267-78.
2. Gaballa MA, Goldman S. Ventricular remodeling in heart failure. J Card Fail 2002;8:476-85.
3. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res 2000;47:23-37.
4. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-62.
5. Neyses L, Pelzer T. The biological cascade leading to cardiac hypertrophy. Eur Heart J 1995;16:8-11.
6. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991;5:3037-46.
7. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 1988;85:339-43.
8. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992;54:227-41.
9. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-54.
10. Schlaich MP, Schmieder RE. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. Am J Hypertens 1998;11:1394-404.
11. Roman MJ, Alderman MH, Pickering TG et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. Am J Hypertens 1998;11:387-96.
12. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541-4.
13. Lee MA, Bohm M, Kim S et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 1995;25:570-80.
14. Campbell DJ, Rong P, Kladis A, Rees B, Ganten D, Skinner SL. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 1995;25:1014-20.
15. Ohta K, Kim S, Wanibuchi H, Ganten D, Iwao H. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats. Circulation 1996;94:785-91.
16. Sandbrink R, Masters CL, Beyreuther K. Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins. J Biol Chem 1994;269:14227-34.
17. Bayer TA, Cappai R, Masters CL, Beyreuther K, Multhaup G. It all sticks together: the APP-related family of proteins and Alzheimer's disease. Mol Psychiatry 1999;4:524-8.
18. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
19. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type I collagen. J Biol Chem 1995;270:2776-83.
20. Hildebrand A, Romaris M, Rasmussen LM et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994;302:527-34.
21. Shihab FS, Andoh TF, Tanner AM, Bennett WM. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis 1997;30:71-81.
22. Ayada Y, Kusachi S, Murakami T et al. Increased expression of biglycan mRNA in pressure-overloaded rat heart. Clin Exp Hypertens 2001;23:633-43.
23. Ahmed MS, Oie E, Vinge LE et al. Induction of myocardial biglycan in heart failure in rats-an extracellular matrix component targeted by AT(1) receptor antagonism. Cardiovasc Res 2003;60:557-68.
24. Hayashi T, Hirshman MF, Kurth EJ, Winder WW,, Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47:1369-73.
25. Kudo N, Gillespie JG, Kung L et al. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1996;1301:67-75.
26. Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001;104:1664-9.
27. Sambandam N, Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 2003;42:238-56.
28. Coven DL, Hu X, Cong L et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab 2003;285:629-36.
29. Daniel T, Carling D. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem 2002;277:51017-24.
30. Ono K, Iwanaga Y, Mannami T et al. Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res 2003;26:685-9.
31. Mohri T, Emoto N, Nonaka H et al. Alterations of circadian expressions of clock genes in Dahl salt-sensitive rats fed a high-salt diet. Hypertension 2003;42:189-94.
32. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 2001;88:1142-50.
33. Pan L, Glenn ST, Jones CA, Gronostajski RM, Gross KW. Regulation of renin enhancer activity by nuclear factor I and Sp1/Sp3. Biochim Biophys Acta 2003;1625:280-90.
34. Rossjohn J, Cappai R, Feil SC et al. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol 1999;6:327-31.
35. Von Koch CS, Zheng H, Chen H et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging 1997;18:661-9.
36. Heber S, Herms J, Gajic V et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 2000;20:7951-63.
37. Dempsey AA, Pabalan N, Tang HC, Liew CC. Organization of human cardiovascular-expressed genes on chromosomes 21 and 22. J Mol Cell Cardiol 2001;33:587-91.
38. Lis CG, Gaviria M. Vascular dementia, hypertension, and the brain. Neurol Res 1997;19:471-80.
39. Skoog I. The relationship between blood pressure and dementia: a review. Biomed Pharmacother 1997;51:367-75.
40. Farrer LA, Sherbatich T, Keryanov SA et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol 2000;57:210-14.
41. Crawford F, Abdullah L, Schinka J et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 2000;280:215-19.
42. Monastero R, Caldarella R, Mannino M et al. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci Lett 2002; 335:147-9.
43. Pachori AS, Numan MT, Ferrario CM, Diz DM, Raizada MK, Katovich MJ. Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy. Hypertension 2002;39:969-75.
44. Sano H, Okamoto H, Kitabatake A, Iizuka K, Murakami T, Kawaguchi H. Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats. Mol Cell Biochem 1998;178:51-8.
45. Jurkovicova D, Dobesova Z, Kunes J, Krizanova O. Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats. Physiol Res 2001;50: 35-42.
46. Sassard J, Lo M, Liu KL. Lyon genetically hypertensive rats: an animal model of "low renin hypertension". Acta Pharmacol Sin 2003;24:1-6.